Scientists test new obesity Drug's hidden effects on common pills
NCT ID NCT06564441
Summary
This study aimed to understand if a new injectable drug for weight management (BI 456906/Survodutide) changes how the body processes three common substances: caffeine, a sleep aid (midazolam), and an antidepressant (bupropion). It involved 34 otherwise healthy adults with overweight or obesity. Researchers measured drug levels in participants' blood before and after they received the new treatment to check for any interactions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
SGS Life Science Services - Clinical Research
Edegem, 2650, Belgium
Conditions
Explore the condition pages connected to this study.